Privacy·Terms·Disclaimer

Bibliographic data courtesy of the U.S. National Library of Medicine (NLM), sourced from PubMed/MEDLINE.

SciRadar is not affiliated with, endorsed by, or sponsored by NLM or NCBI. Abstracts remain © their respective publishers.

CD19 CAR T-Cell Therapy for Refractory Ulcerative Colitis. — SciRadar

Back to results

Gastroenterology

CD19 CAR T-Cell Therapy for Refractory Ulcerative Colitis.

Irene Marafini, Silvia Salvatori, Edoardo Troncone, Giovanni Monteleone

Published: 202510.1053/j.gastro.2025.11.013

No abstract available for this study.